Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Erixon Medtech AB
AB
Active
Org 5591321988
Industrigatan 44 B, 571 38
Nässjö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Erixon Medtech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
5M
4M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 752
1 046
1 085
1 301
887
Staff expenses
—
—
−493
−530
−220
EBITDA
1 008
−303
100
51
−137
Depreciation & amort.
−21
−33
−29
−19
−14
EBIT
987
−336
70
33
−151
Net financials
—
—
0
0
0
Profit before tax
747
−96
70
33
−151
Tax
−160
−0
—
−9
—
Net profit
587
−96
70
24
−151
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 159
1 402
1 300
1 325
1 200
Equity
717
622
692
716
565
Long-term debt
477
475
475
480
480
Short-term debt
725
305
133
129
154
Total debt
1 202
780
608
609
634
Financial ratios
5-year trend
EBITDA margin
-15.5%
This company
15.8%
Market median
-198% vs market
2020
2024
Equity ratio
47.1%
This company
38.2%
Market median
+23% vs market
2020
2024
Return on equity
-26.7%
This company
18.4%
Market median
-245% vs market
2020
2024
Net profit margin
-17.0%
This company
8.1%
Market median
-310% vs market
2020
2024
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
2020
2024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Erixon Medtech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
